Suppr超能文献

人血浆激肽释放酶。蛋白质和肽水解的初步研究。

Human plasma kallikrein. Preliminary studies on hydrolysis of proteins and peptides.

作者信息

Sampaio C A, Grisolia D

出版信息

Agents Actions. 1978 Jan;8(1-2):125-31. doi: 10.1007/BF01972414.

Abstract

Acid-activated human plasma kallikrein (HuPK) was purified from human Cohn fraction IV by affinity chromatography, using a ligand soybean trypsin inhibitor and aminobenzamidine. The purified enzyme does not inactivate bradykinin and lysyl-bradykinin by cleavage of their peptide bonds. Methionyl-lysyl-bradykinin is converted to the more potent peptide, bradykinin, by incubation with plasma kallikrein. The enzyme does not show aminopeptidase activity when assayed with amino-acyl-naphthylamides. Arginine-rich polypeptides and proteins, such as polyarginine, salmine, and histones were cleaved by the enzyme. HuPK does not show any detectable caseinolytic activity. A kinin is released from a non-homologous plasma (horse) by this kallikrein. The enzyme is not affected by calcium or EDTA, and it is strongly inhibited by copper ion.

摘要

使用配体大豆胰蛋白酶抑制剂和氨基苯甲脒,通过亲和色谱法从人Cohn IV组分中纯化酸激活的人血浆激肽释放酶(HuPK)。纯化后的酶不会通过切割肽键使缓激肽和赖氨酰缓激肽失活。通过与血浆激肽释放酶孵育,甲硫氨酰 - 赖氨酰缓激肽可转化为活性更强的肽——缓激肽。用氨酰萘胺测定时,该酶不显示氨肽酶活性。富含精氨酸的多肽和蛋白质,如聚精氨酸、鲑精蛋白和组蛋白可被该酶切割。HuPK未显示出任何可检测到的酪蛋白分解活性。这种激肽释放酶可从非同源血浆(马)中释放出一种激肽。该酶不受钙或乙二胺四乙酸(EDTA)的影响,但会被铜离子强烈抑制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验